Correlation Between Orphazyme and BioPorto

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Orphazyme and BioPorto at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orphazyme and BioPorto into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orphazyme AS and BioPorto, you can compare the effects of market volatilities on Orphazyme and BioPorto and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orphazyme with a short position of BioPorto. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orphazyme and BioPorto.

Diversification Opportunities for Orphazyme and BioPorto

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Orphazyme and BioPorto is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Orphazyme AS and BioPorto in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioPorto and Orphazyme is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orphazyme AS are associated (or correlated) with BioPorto. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioPorto has no effect on the direction of Orphazyme i.e., Orphazyme and BioPorto go up and down completely randomly.

Pair Corralation between Orphazyme and BioPorto

Assuming the 90 days trading horizon Orphazyme AS is expected to generate 1.49 times more return on investment than BioPorto. However, Orphazyme is 1.49 times more volatile than BioPorto. It trades about -0.2 of its potential returns per unit of risk. BioPorto is currently generating about -0.51 per unit of risk. If you would invest  107,660  in Orphazyme AS on August 28, 2024 and sell it today you would lose (16,160) from holding Orphazyme AS or give up 15.01% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Orphazyme AS  vs.  BioPorto

 Performance 
       Timeline  
Orphazyme AS 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Orphazyme AS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Orphazyme is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
BioPorto 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioPorto has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Orphazyme and BioPorto Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Orphazyme and BioPorto

The main advantage of trading using opposite Orphazyme and BioPorto positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orphazyme position performs unexpectedly, BioPorto can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioPorto will offset losses from the drop in BioPorto's long position.
The idea behind Orphazyme AS and BioPorto pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Transaction History
View history of all your transactions and understand their impact on performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets